Fonteyne V - Search Results

1

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.

Sutera PA, Shetty AC, Hakansson A, Van der Eecken K, Song Y, Liu Y, Chang J, Fonteyne V, Mendes AA, Lumen N, Delrue L, Verbeke S, De Man K, Rana Z, Hodges T, Hamid A, Roberts N, Song DY, Pienta K, Ross AE, Feng F, Joniau S, Spratt D, Gillessen S, Attard G, James ND, Lotan T, Davicioni E, Sweeney C, Tran PT, Deek MP, Ost P. Sutera PA, et al. Among authors: fonteyne v. Ann Oncol. 2023 Jul;34(7):605-614. doi: 10.1016/j.annonc.2023.04.515. Epub 2023 May 8. Ann Oncol. 2023. PMID: 37164128 Free PMC article.

2

Review of hypo-fractionated radiotherapy for localized muscle invasive bladder cancer.

Amestoy F, Roubaud G, Antoine M, Fonteyne V, Baumann BC, Christodouleas J, Roupret M, Azria D, Zilli T, Hennequin C, Xylinas E, Sargos P; Young Academic Urologists Urothelial Carcinoma Group of the European Association of Urology. Amestoy F, et al. Among authors: fonteyne v. Crit Rev Oncol Hematol. 2019 Oct;142:76-85. doi: 10.1016/j.critrevonc.2019.06.010. Epub 2019 Jul 16. Crit Rev Oncol Hematol. 2019. PMID: 31377435

3

Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.

Roelofs E, Engelsman M, Rasch C, Persoon L, Qamhiyeh S, de Ruysscher D, Verhaegen F, Pijls-Johannesma M, Lambin P; ROCOCO Consortium. Roelofs E, et al. J Thorac Oncol. 2012 Jan;7(1):165-76. doi: 10.1097/JTO.0b013e31823529fc. J Thorac Oncol. 2012. PMID: 22071782 Free article. Clinical Trial.

4

Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.

Fonteyne V, Villeirs G, Speleers B, De Neve W, De Wagter C, Lumen N, De Meerleer G. Fonteyne V, et al. Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):799-807. doi: 10.1016/j.ijrobp.2008.01.040. Epub 2008 Apr 11. Int J Radiat Oncol Biol Phys. 2008. PMID: 18407430

5

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W. De Meerleer G, et al. Among authors: fonteyne v. Radiother Oncol. 2008 Nov;89(2):205-13. doi: 10.1016/j.radonc.2008.07.027. Epub 2008 Sep 2. Radiother Oncol. 2008. PMID: 18771809

6

Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.

Fonteyne V, Villeirs G, Lumen N, De Meerleer G. Fonteyne V, et al. Radiother Oncol. 2009 Jul;92(1):42-7. doi: 10.1016/j.radonc.2009.03.013. Epub 2009 Apr 6. Radiother Oncol. 2009. PMID: 19356817 Clinical Trial.

7

Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Ost P, Fonteyne V, Villeirs G, Lumen N, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: fonteyne v. Eur Urol. 2009 Oct;56(4):669-75. doi: 10.1016/j.eururo.2009.05.041. Epub 2009 May 29. Eur Urol. 2009. PMID: 19501453

8

Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience.

De Meerleer G, Vandecasteele K, Ost P, Delrue L, Denys H, Makar A, Speleers B, Van Belle S, Van den Broecke R, Fonteyne V, De Neve W. De Meerleer G, et al. Among authors: fonteyne v. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):775-81. doi: 10.1016/j.ijrobp.2009.11.039. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20421155

9

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.

Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, De Gersem W. Ost P, et al. Among authors: fonteyne v. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):920-6. doi: 10.1016/j.ijrobp.2010.04.025. Epub 2010 Aug 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675077

10

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.

Ost P, De Troyer B, Fonteyne V, Oosterlinck W, De Meerleer G. Ost P, et al. Among authors: fonteyne v. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1316-22. doi: 10.1016/j.ijrobp.2010.04.039. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters